Honey Blankenship/LinkedIn
Aug 16, 2026, 13:53
Honey Blankenship: United by a Shared Commitment to the Bleeding Disorders Community
Honey Blankenship, Hemophilia Patient Navigator at Pfizer, shared on LinkedIn:
”Coming home from an incredible conference feeling especially grateful.
Grateful for the patients, healthcare providers, advocacy groups, and industry partners who came together with a shared commitment to making a difference for the bleeding disorders community.
Most of all, I’m grateful for the relationships and lifelong friendships that continue to grow through this work.
I feel incredibly fortunate to work for a company that gives me the opportunity to support patients and contribute to a community that inspires me every day.
Leaving with a full heart, new connections, and even more motivation for the work ahead.”
Stay updated with Hemostasis Today.
-
Oct 11, 2026, 12:11Carmine Siniscalchi: Could LDL Cholesterol Help Us Better Predict Bleeding Risk in Patients with VTE?
-
Oct 11, 2026, 12:03What is ITP? Raising Awareness for Immune Thrombocytopenia – ITP Australia and New Zealand
-
Oct 11, 2026, 11:55Gauri Jayasinghe: Privileged to Serve as Resource Person for the Blood Transfusion Essentials Programme
-
Oct 11, 2026, 11:49Toby Richards: New Definitions for Iron Deficiency Delighted to Be in the USA with the New ASH Guidelines
-
Oct 11, 2026, 11:44Lesley Van Wyk: ASCP High-Yield Review – Essential Thalassemia Concepts and Differential Diagnosis
-
Oct 11, 2026, 11:37Susanne Pass: Key Takeaways from ESVS 2026 Workshops in Belgrade
-
Oct 11, 2026, 10:44Logesh. M: Managing Warfarin-Associated Recurrent Epistaxis and Anticoagulant Safety
-
Oct 11, 2026, 10:28Sébastien Béland: Validating RUDAS for Detecting Neurocognitive Impairment in Sickle Cell Disease
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia